Sep 2026· UF Journal of Undergraduate Research· 0 citations
TL;DR
Results suggest that apoptotic and pyroptotic pathways are not active in these tissue samples, suggesting that alternative cell death pathways, such as necroptosis, may be responsible, or these animals had not undergone significant cardiomyocyte cell death.
Abstract
Duchenne muscular dystrophy (DMD) is a genetic disorder caused by mutations in the DMD gene, resulting in the loss of dystrophin protein. Dystrophin is expressed in striated muscle and stabilizes the sarcolemma during muscle contraction; its absence leads to rapid muscle degeneration. Cardiomyopathy is the leading cause of death for DMD patients, with aberrant calcium mishandling in dystrophic cardiomyocytes representing a contributing mechanism. However, the cell death pathway underlying cardiomyocyte death remains poorly understood. To identify dystrophic cardiomyocyte cell death mechanisms, cardiac tissue from three wild-type and four D2.mdx mice (male, aged 12 months) were analyzed for proteins that regulate common apoptotic and pyroptotic pathways (caspases –1, 3, and 9) and their downstream cleavage products (IL-1β, IL-18, and poly (ADP-ribose) polymerase-1 (PARP)). Results show that pro-caspase-1 and IL-1β expression is not significantly different between groups (p = 0.306 and 0.125, respectively). Similarly, cleaved PARP levels did not differ significantly between groups (p = 0.128). These results suggest that apoptotic and pyroptotic pathways are not active in these tissue samples. Alternative cell death pathways, such as necroptosis, may be responsible, or these animals had not undergone significant cardiomyocyte cell death.
Through multidisciplinary treatment and continuous scientific progress, individualized precision medicine that integrates therapies targeting secondary pathogenic pathways with dystrophin-restoration techniques can finally convert this devastating illness into a tolerable chronic ailment.
Shahjad Ansari, Mohd Amaan Saifi, Sarfaraz Ahmed et al.· Current pharmaceutical desig...· 0 citations
Duchenne muscular dystrophy (DMD) is an X-linked muscle wasting disorder marked by lack of dystrophin expression. Symptoms include loss of ambulation, respiratory problems, and cardiac complications with heart failure being the leading cause of death. Dystrophin transduces force from the actin cytoskeleton to the extra...
Elaine C. Lai, Abiageal R. Keegan, A. Eguchi· bioRxiv· 0 citations
DMD is a severe, progressive X-linked recessive neuromuscular disorder caused by pathogenic mutations in the DMD gene, resulting in deficiency or absence of the dystrophin protein, and multidisciplinary management has improved survival and quality of life.
B. Rakesh, A. A, D. S. et al.· International Journal of Res...· 0 citations
Duchenne muscular dystrophy (DMD) is a fatal disorder caused by dystrophin mutations, leading to progressive muscle degeneration and cardiac failure. Although AAV-based DMD therapies with innovative designs to overcome the cargo limits of the virus are effective in animal models, these current systems may face clinical...
Ryan H. Hsu, Claire E. Williams, Geraldine Maier et al.· bioRxiv· 0 citations
The Popeye domain-containing protein 1 (Popdc1, also known as Bves) is a transmembrane protein whose dysfunction is closely associated with various diseases. Clinical studies have identified that mutations in the bves gene predispose individuals to limb-girdle muscular dystrophy. However, a marked reduction in Bves pro...
Wanwan Cai, Wan-Bang Zhou, Jun-Rong Lei et al.· Life Science· 0 citations
Duchenne muscular dystrophy (DMD) is a lethal degenerative muscle disease. DMD results from mutations preventing the production of the subsarcolemmal protein dystrophin, a protein critical for muscle stability. In the absence of dystrophin, muscle fibers are damaged and degenerate, leading to an inflamed and fibrotic m...
Matthew J Burke· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.